John C. Burnett

42.4k citations

577 papers · 32.0k indexed · 8 hit papers · h-index 92

Impact in

Cardiology and Cardiovascular Medicine top 0.01%
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Renin-Angiotensin System Studies
- Cardiac pacing and defibrillation studies
- Cardiac electrophysiology and arrhythmias
Nephrology top 0.2%

Papers in

Cardiology and Cardiovascular Medicine 440
- Heart Failure Treatment and Management 312
- Cardiovascular Function and Risk Factors 108
- Renin-Angiotensin System Studies 49
- Cardiac pacing and defibrillation studies 36
Nephrology 34

Co-authors: Margaret M. Redfield Richard J. Rodeheffer Denise M. Heublein Kent R. Bailey Steven J. Jacobsen Douglas W. Mahoney Amir Lerman Michihisa Jougasaki
Journals: Journal of the American College of Cardiology (58 papers)Journal of Cardiac Failure (56 papers)Circulation (51 papers)American Journal of Physiology-Regulatory, Integrative and Comparative Physiology (32 papers)Hypertension (26 papers)
Partner nations: United States Italy Germany

In The Last Decade

John C. Burnett

568 papers receiving 31.0k citations

Hit Papers

8 papers align trajectories log scale

Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure 2019 · 248 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Pharmacological Reviews
2013 European Heart Journal
2011 JAMA
2003 JAMA
2002 Journal of the American College of Cardiology
1992 New England Journal of Medicine
1991 New England Journal of Medicine
1984 American Journal of Physiology-Renal Physiology

Peers

Countries citing papers authored by John C. Burnett

Since Specialization

Citations

This map shows the geographic impact of John C. Burnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Burnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Burnett more than expected).

Fields of papers citing papers by John C. Burnett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Burnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Burnett. The network helps show where John C. Burnett may publish in the future.

Co-authors

The 25 scholars most cited alongside John C. Burnett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John C. Burnett Line = papers co-authored together John C. Burnett links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Abstract 16504: Synergist Actions of the Bispecific Peptide, NPA7, and Furosemide in Experimental Heart Failure Circulation ·Laura M.G. Meems, Yang Chen, Gail J. Harty, Jerry Harders, Seetha R Iyer, Denise M. Heublein, John C. Burnett	2017	1
2	Abstract 12893: Design and cGMP-Generating Actions of a Novel Selective and Non-Selective Particulate Guanylyl Cyclase B Activator Targeting Cardiorenal Fibrotic Remodeling Circulation ·S. Jeson Sangaralingham, Brenda K. Huntley, Tomoko Ichiki, John C. Burnett	2016	1
3	Dietary Sodium Modulation of Aldosterone Activation and Renal Function During the Progression of Experimental Heart Failure European Journal of Heart Failure ·Wayne L. Miller, Daniel D. Borgeson, J. Aaron Grantham, Andreas Luchner, Margaret M. Redfield, John C. Burnett	2014	19
4	Abstract 14201: ANX-042, a Novel Natriuretic Peptide (NP), is Safe and Stimulates Cyclic Guanosine Monophosphate (cGMP) in Healthy Volunteers Circulation ·Horng H. Chen, Robert D. Simari, Stephen P. Youngberg, Donna R. Grogan, Jeffrey W. Miller, John C. Burnett	2013	2
5	Furosemide—to DOSE or not to DOSE, that is the question Nature Reviews Cardiology ·Lisa C. Costello‐Boerrigter, John C. Burnett	2011	1
6	Predictive Utility of Atrial, N-Terminal Pro-Atrial, and N-Terminal Pro-B-Type Natriuretic Peptides for Mortality and Cardiovascular Events in the General Community: A 9-Year Follow-up Study Mayo Clinic Proceedings ·Paul M. McKie, Alessandro Cataliotti, S. Jeson Sangaralingham, Tomoko Ichiki, Valentina Cannone, Kent R. Bailey, Margaret M. Redfield, Richard J. Rodeheffer, John C. Burnett	2011	49
7	The Aging Heart, Myocardial Fibrosis, and its Relationship to Circulating C-Type Natriuretic Peptide Hypertension ·S. Jeson Sangaralingham, Brenda K. Huntley, Fernando L. Martín, Paul M. McKie, Diego Bellavia, Tomoko Ichiki, Gerald E. Harders, Horng H. Chen, John C. Burnett	2010	94
8	Natriuretic Peptides in the Diagnosis and Management of Chronic Heart Failure Heart Failure Clinics ·Guido Boerrigter, Lisa C. Costello‐Boerrigter, John C. Burnett	2009	51
9	Abstract 1485: Tissue Specific Activation of cGMP by an Alternatively Spliced Form of BNP Circulation ·Shuchong Pan, Candace Lee, Horng Chen, Amir Lerman, John C. Burnett, Robert D. Simari	2008	1
10	Prevalence and Prognostic Significance of Heart Failure Stages Circulation ·Khawaja Afzal Ammar, Steven J. Jacobsen, Douglas W. Mahoney, Jan A. Kors, Margaret M. Redfield, John C. Burnett, Richard J. Rodeheffer	2007	351
11	Intact Acute Cardiorenal and Humoral Responsiveness Following Chronic Subcutaneous Administration of the Cardiac Peptide BNP in Experimental Heart Failure European Journal of Heart Failure ·Horng H. Chen, John A. Schirger, Alessandro Cataliotti, John C. Burnett	2006	12
12	Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General Community Journal of the American College of Cardiology ·Lisa C. Costello‐Boerrigter, Guido Boerrigter, Margaret M. Redfield, Richard J. Rodeheffer, Lynn H. Urban, Douglas W. Mahoney, Steven J. Jacobsen, Denise M. Heublein, John C. Burnett	2006	305
13	Brown is Best John C. Burnett	2005	2
14	A Pilot Study of Dendroaspis Natriuretic Peptide in Aneurysmal Subarachnoid Hemorrhage Neurosurgery ·Vini G. Khurana, Eelco F. M. Wijdicks, Denise M. Heublein, Robyn L. McClelland, Fredric B. Meyer, David G. Piepgras, John C. Burnett	2004	18
15	Decompensated Heart Failure: Is There a Role for the Outpatient Use of Nesiritide? Congestive Heart Failure ·Clyde W. Yancy, John C. Burnett, Gregg C. Fonarow, Marc A. Silver	2004	3
16	Subcutaneous administration of brain natriuretic peptide in experimental heart failure Journal of the American College of Cardiology ·Horng H Chen, J. Aaron Grantham, John A. Schirger, Michihisa Jougasaki, Margaret M. Redfield, John C. Burnett	2000	59
17	Vasopeptidase inhibition Current Opinion in Nephrology & Hypertension ·John C. Burnett	2000	18
18	Dual inhibition of neutral endopeptidase and angiotensin converting enzyme delays the progression of experimental heart failure Journal of the American College of Cardiology ·Tracy L. Stevens, Daniel D. Borgeson, Margaret M. Redfield, Andreas Luchner, John C. Burnett	1996	2
19	Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation Kidney International ·Stephen C. Textor, John C. Burnett, J. Carlos Romero, Vincent J. Canzanello, Sandra J. Taler, Russell H. Wiesner, Michael K. Porayko, Ruud A. F. Krom, Gregory J. Gores, Eileen J. Hay	1995	76
20	Expression of atrial natriuretic factor in the human ventricle is independent of chamber dilation Journal of the American College of Cardiology ·Brooks S. Edwards, Richard J. Rodeheffer, Guy S. Reeder, John C. Burnett	1990	12

About John C. Burnett

John C. Burnett is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology, Physiology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 577 papers that have together received 32.0k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (312 papers), Cardiovascular Function and Risk Factors (108 papers), Nitric Oxide and Endothelin Effects (70 papers), Renin-Angiotensin System Studies (49 papers), Peptidase Inhibition and Analysis (44 papers), Receptor Mechanisms and Signaling (42 papers), Cardiac pacing and defibrillation studies (36 papers) and Electrolyte and hormonal disorders (33 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (22.9k citations), Nephrology (1.9k citations), Physiology (5.2k citations), Pulmonary and Respiratory Medicine (5.5k citations) and Endocrinology, Diabetes and Metabolism (2.7k citations). John C. Burnett has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Margaret M. Redfield, Richard J. Rodeheffer, Denise M. Heublein, Kent R. Bailey, Steven J. Jacobsen, Douglas W. Mahoney, Amir Lerman, Michihisa Jougasaki, Horng H. Chen and Guido Boerrigter. Their work appears in journals such as Journal of the American College of Cardiology, Journal of Cardiac Failure, Circulation, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology and Hypertension.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact